TTD Drug ID: DAP000666

Drug Information
Name	Piperazine
Synonyms	NCIOpen2_005575; D00807; NCIOpen2_001151; NCIOpen2_005182; NCIOpen2_005200; PZE; 1,4-Diethylenediamine; 1,4-Diazacyclohexane; Diethylenediamine; LTBB000432; Anthalazine; EINECS 203-808-3; 1951-97-9 (unspecified phosphate); P45907_SIAL; NCIOpen2_004982; NCIOpen2_004862; UN2579; Piperazin [German]; ARONIS23910; Worm-A-Ton; Spectrum_001113; Pyrazine, hexahy; 110-85-0; P0447; Wurmirazin; NCIOpen2_004952; NCIOpen2_005108; 80621_FLUKA; BIDD:GT0273; NCIOpen2_004914; IDI1_000038; NCIOpen2_004904; NCIOpen2_004874; Spectrum5_001817; Hexahydropyrazine; NCIOpen2_001231; NCIOpen2_005980; CCRIS 5950; NCIOpen2_001033; 8017-90-1; KBio2_006729; HMS2092A03; Vermex; Dispermine; NCIOpen2_004834; 16832-43-2 (unspecified hydrate); Pyrazine, hexahydro-; NCIOpen2_000984; Lumbrical; CHEBI:28568; NCIOpen2_005145; nchembio814-comp12; NINDS_000038; DivK1c_000038; NCIOpen2_001073; C07973; HSDB 1093; KBio2_001593; NCIOpen2_000988; InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H; Piperazine anhydrous; NCIOpen2_004830; Pipersol; 5-23-01-00030 (Beilstein Handbook Reference); Piperazine, anhydrous; Jsp000824; Eraverm; KBioSS_001593; NSC 474; Piperazin [Germany]; 14538-56-8 (phosphate[1:1]); P0446; NCIOpen2_004954; AR-1L1009; 854880-15-2; NCIOpen2_005072; AC1Q1IA7; NCGC00094762-02; Piperazine [UN2579] [Corrosive]; Piperazine [USAN]; BRN 0102555; DB00592; Pyrazine hexahydride; KBio2_004161; NCIOpen2_005034; Piperazine Hexa-Hydrate; 142-63-2 (hexahydrate); 1,4-Diazacyclohexane; UNII-1RTM4PAL0V; NCIOpen2_004994; KBio1_000038; Asca-Trol No. 3; 8057-14-5 (unspecified salt); NCIOpen2_001269; NCIOpen2_001111; Worm-away; NCIOpen2_001262; HMS500B20; Vermizine (TN); Eraverm (VAN); PIPERAZINE (HEXAHYDRATE); CID4837; NCIOpen2_005102; Piperazine [UN2579] [Corrosive]; 8027-81-4; MolPort-000-872-010; AKOS000269028; dro-; piperazinium oleate; LS-517; NCIOpen2_005187; SPECTRUM1500490; NCIOpen2_005062; NCIOpen2_001031; 1,4-Piperazine; Uvilon; NCIOpen2_001024; AC1Q1IA9; piperazine; AC1L1J2E; NCGC00094762-01; NCIOpen2_004942; Upixon; 7542-23-6 (mono-hydrochloride); Piperazine Dihydrochloride Dihydrochloride Hydrate; NCIOpen2_005022; 6094-40-2 (unspecified hydrochloride); AB1003720; I14-11172; Hexahydro-1,4-diazine; NCIOpen2_001071; HMS1920H20; 3597-26-0 (unspecified sulfate); NCIOpen2_004910; WLN: T6M DMTJ; 142-64-3 (di-hydrochloride); Piperazidine; NCIOpen2_005032; AC1Q1IA8; CHEMBL1412; Diethylenediamine; Antiren; NCIOpen2_005185; Diethyleneimine; Vermizine; NCIOpen2_004992; NCIOpen2_009422; Piperazin; Piperazine (USP); NSC474; 14007-05-7 (unspecified hydrobromide); 861800-35-3
Indication	Ascariasis and enterobiasis [ICD9: 127.0, 127.4   ICD10: B77, B80]			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
InChI	1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2
InChIKey	GLUUGHFHXGJENI-UHFFFAOYSA-N
Canonical SMILES	C1CNCCN1
Therapeutic Class	Antinematodal Agents
CAS Number	CAS 110-85-0
Formula	C4H10N2
PubChem Compound ID	CID 4837.
PubChem Substance ID	SID 10174.
ChEBI	28568;
SuperDrug ATC ID	P02CB01
SuperDrug CAS ID	000054911;
Target	Gamma-aminobutyric acid receptor			Antagonist	[2]
Ref 1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 080671 To Reference
Ref 2	Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents. 2003 Sep;22(3):318-31. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.